Christopher L. Lynch

2.6k total citations · 1 hit paper
10 papers, 1.7k citations indexed

About

Christopher L. Lynch is a scholar working on Molecular Biology, Organic Chemistry and Microbiology. According to data from OpenAlex, Christopher L. Lynch has authored 10 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Microbiology. Recurrent topics in Christopher L. Lynch's work include Sphingolipid Metabolism and Signaling (4 papers), Lipid Membrane Structure and Behavior (4 papers) and Chemical Synthesis and Analysis (3 papers). Christopher L. Lynch is often cited by papers focused on Sphingolipid Metabolism and Signaling (4 papers), Lipid Membrane Structure and Behavior (4 papers) and Chemical Synthesis and Analysis (3 papers). Christopher L. Lynch collaborates with scholars based in United States. Christopher L. Lynch's co-authors include Jeffrey J. Hale, James D. Bergstrom, James A. Milligan, Mark Rosenbach, Richard Hajdu, Deborah Card, Suzanne Mandala, Gan-Ju Shei, Hugh Rosen and William H. Parsons and has published in prestigious journals such as Science, Journal of the American Chemical Society and Biochemistry.

In The Last Decade

Christopher L. Lynch

10 papers receiving 1.7k citations

Hit Papers

Alteration of Lymphocyte Trafficking by Sphingosine-1-Pho... 2002 2026 2010 2018 2002 400 800 1.2k

Peers

Christopher L. Lynch
Kathleen M. Rupprecht United States
Gan-Ju Shei United States
Jenny Xie United States
Christian Beerli Switzerland
T. INAZU Japan
Oliver Rausch United Kingdom
Dmitri Kapitonov United States
Hakryul Jo United States
Holly K. Koblish United States
Kathleen M. Rupprecht United States
Christopher L. Lynch
Citations per year, relative to Christopher L. Lynch Christopher L. Lynch (= 1×) peers Kathleen M. Rupprecht

Countries citing papers authored by Christopher L. Lynch

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Lynch more than expected).

Fields of papers citing papers by Christopher L. Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Lynch. The network helps show where Christopher L. Lynch may publish in the future.

Co-authorship network of co-authors of Christopher L. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Lynch. A scholar is included among the top collaborators of Christopher L. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Lynch. Christopher L. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yan, Lin, Richard J. Budhu, Christopher L. Lynch, et al.. (2006). 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters. 16(13). 3564–3568. 18 indexed citations
2.
Yan, Lin, Jeffrey J. Hale, Christopher L. Lynch, et al.. (2004). Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters. 14(19). 4861–4866. 23 indexed citations
3.
Hale, Jeffrey J., Christopher L. Lynch, William Neway, et al.. (2004). A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists. Journal of Medicinal Chemistry. 47(27). 6662–6665. 65 indexed citations
4.
Castonguay, Laurie A., Jerry Di Salvo, Charles G. Caldwell, et al.. (2003). Binding of 2-Aryl-4-(piperidin-1-yl)butanamines and 1,3,4-Trisubstituted Pyrrolidines to Human CCR5:  A Molecular Modeling-Guided Mutagenesis Study of the Binding Pocket. Biochemistry. 42(6). 1544–1550. 60 indexed citations
5.
Lynch, Christopher L., et al.. (2003). 1,3,4‐Trisubstituted Pyrrolidine CCR5 Receptor Antagonists: Modifications of Arylpropylpiperidine Side Chains.. ChemInform. 34(22). 1 indexed citations
6.
Mandala, Suzanne, Richard Hajdu, James D. Bergstrom, et al.. (2002). Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists. Science. 296(5566). 346–349. 1398 indexed citations breakdown →
7.
Liras, Spiros, Christopher L. Lynch, Andrew M. Fryer, Binh Thanh Vu, & Stephen F. Martin. (2001). Applications of Vinylogous Mannich Reactions. Total Syntheses of the Ergot Alkaloids Rugulovasines A and B and Setoclavine. Journal of the American Chemical Society. 123(25). 5918–5924. 74 indexed citations
8.
Martin, Stephen F., Michael P. Dwyer, & Christopher L. Lynch. (1998). Application of AlMe3-mediated amidation reactions to solution phase peptide synthesis. Tetrahedron Letters. 39(12). 1517–1520. 20 indexed citations
9.
Solomon, Michael E., Christopher L. Lynch, & Daniel H. Rich. (1996). Efficient Synthesis of Tosyl-aziridine-2-t-butyl Carboxylate. Synthetic Communications. 26(14). 2723–2729. 8 indexed citations
10.
Solomon, Michael E., Christopher L. Lynch, & Daniel H. Rich. (1995). Synthesis of Nα, Nβ-alkylated diaminopropionic acid analogs. Tetrahedron Letters. 36(28). 4955–4958. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026